Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kenneth Alan Freedberg, M.D.

Co-Author

This page shows the publications co-authored by Kenneth Freedberg and Ingrid Bassett.
Connection Strength

6.101
  1. Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2015 Nov; 10(6):451-63.
    View in: PubMed
    Score: 0.638
  2. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PLoS One. 2014; 9(1):e85197.
    View in: PubMed
    Score: 0.564
  3. Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa. Clin Infect Dis. 2010 Oct 01; 51(7):823-9.
    View in: PubMed
    Score: 0.449
  4. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr. 2009 Jun 01; 51(2):135-9.
    View in: PubMed
    Score: 0.409
  5. Using national laboratory data to assess cumulative frequency of linkage after transfer to community-based HIV clinics in South Africa. J Int AIDS Soc. 2019 06; 22(6):e25326.
    View in: PubMed
    Score: 0.204
  6. Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa. Open Forum Infect Dis. 2017; 4(3):ofx167.
    View in: PubMed
    Score: 0.181
  7. Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa. J Acquir Immune Defic Syndr. 2017 04 01; 74(4):432-438.
    View in: PubMed
    Score: 0.176
  8. Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South Africa. Pediatr Infect Dis J. 2017 03; 36(3):311-313.
    View in: PubMed
    Score: 0.175
  9. Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South Africa. J Acquir Immune Defic Syndr. 2016 Oct 01; 73(2):154-60.
    View in: PubMed
    Score: 0.170
  10. Age Matters: Increased Risk of Inconsistent HIV Care and Viremia Among Adolescents and Young Adults on Antiretroviral Therapy in Nigeria. J Adolesc Health. 2016 09; 59(3):298-304.
    View in: PubMed
    Score: 0.167
  11. Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South Africa. AIDS Behav. 2015 Oct; 19(10):1888-95.
    View in: PubMed
    Score: 0.159
  12. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal. HIV Med. 2015 Nov; 16(10):640-4.
    View in: PubMed
    Score: 0.154
  13. HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years. Int J STD AIDS. 2015 Sep; 26(10):704-9.
    View in: PubMed
    Score: 0.148
  14. The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa. Open Forum Infect Dis. 2014 Sep; 1(2):ofu058.
    View in: PubMed
    Score: 0.147
  15. Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis. 2014 Feb 26; 14:110.
    View in: PubMed
    Score: 0.142
  16. Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis. 2014 Mar; 14(3):239-49.
    View in: PubMed
    Score: 0.140
  17. Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa. HIV Med. 2014 Jul; 15(6):367-72.
    View in: PubMed
    Score: 0.139
  18. A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial. BMC Infect Dis. 2013 Aug 26; 13:390.
    View in: PubMed
    Score: 0.137
  19. Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa. PLoS One. 2013; 8(4):e62362.
    View in: PubMed
    Score: 0.134
  20. Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa. PLoS One. 2013; 8(1):e55305.
    View in: PubMed
    Score: 0.132
  21. Improving HIV outcomes in resource-limited countries: the importance of quality indicators. BMC Health Serv Res. 2012 Nov 24; 12:427.
    View in: PubMed
    Score: 0.130
  22. Depressive symptoms and their impact on health-seeking behaviors in newly-diagnosed HIV-infected patients in Durban, South Africa. AIDS Behav. 2012 Nov; 16(8):2226-35.
    View in: PubMed
    Score: 0.130
  23. Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa. PLoS One. 2012; 7(8):e43281.
    View in: PubMed
    Score: 0.128
  24. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa. J Acquir Immune Defic Syndr. 2012 Jan 01; 59(1):25-30.
    View in: PubMed
    Score: 0.122
  25. Screening for acute HIV infection in South Africa: finding acute and chronic disease. HIV Med. 2011 Jan; 12(1):46-53.
    View in: PubMed
    Score: 0.114
  26. The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010 Mar 04; 5(3):e9538.
    View in: PubMed
    Score: 0.108
  27. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS. 2010 Jan; 24 Suppl 1:S37-44.
    View in: PubMed
    Score: 0.106
  28. Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infection. HIV Med. 2008 Nov; 9(10):863-7.
    View in: PubMed
    Score: 0.097
  29. Routine voluntary HIV testing in Durban, South Africa: the experience from an outpatient department. J Acquir Immune Defic Syndr. 2007 Oct 01; 46(2):181-6.
    View in: PubMed
    Score: 0.091
  30. Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV. Clin Infect Dis. 2004 Aug 01; 39(3):395-401.
    View in: PubMed
    Score: 0.073
  31. Modeling Adherence Interventions Among Youth with HIV in the United States: Clinical and Economic Projections. AIDS Behav. 2021 Sep; 25(9):2973-2984.
    View in: PubMed
    Score: 0.057
  32. Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161). JMIR Res Protoc. 2019 Apr 16; 8(4):e9898.
    View in: PubMed
    Score: 0.051
  33. Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort. BMC Infect Dis. 2019 Jan 05; 19(1):14.
    View in: PubMed
    Score: 0.050
  34. Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients. Int J Tuberc Lung Dis. 2018 11 01; 22(11):1366-1373.
    View in: PubMed
    Score: 0.049
  35. High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian Cohort. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):322-328.
    View in: PubMed
    Score: 0.048
  36. Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort. J Int Assoc Provid AIDS Care. 2017 Jan/Feb; 16(1):98-104.
    View in: PubMed
    Score: 0.043
  37. High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria. BMC Infect Dis. 2015 Sep 30; 15:397.
    View in: PubMed
    Score: 0.040
  38. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis. PLoS Med. 2014 Sep; 11(9):e1001725.
    View in: PubMed
    Score: 0.037
  39. Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. PLoS One. 2013; 8(11):e80017.
    View in: PubMed
    Score: 0.035
  40. The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South Africa. J Acquir Immune Defic Syndr. 2011 Jan 01; 56(1):26-35.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.